Archer Capital related stories
All articles and analysis
Archer-led consortium to buy Australian toy companyA consortium led by Archer Capital has already acquired 22 million shares, bringing its interest in the company to 18.8 percent.
- CHAMP plots latest Australian PTP(4)
CHAMP Private Equity has become the latest of the established Sydney-based private equity managers to stage a take-private attempt. The target is Melbourne manufacturer Nylex Limited.
- CHAMP plots latest Australian PTP(3)
CHAMP Private Equity has become the latest of the established Sydney-based private equity managers to stage a take-private attempt. The target is Melbourne manufacturer Nylex Limited.
- CHAMP plots latest Australian PTP(2)
CHAMP Private Equity has become the latest of the established Sydney-based private equity managers to stage a take-private attempt. The target is Melbourne manufacturer Nylex Limited.
- CHAMP plots latest Australian PTP
CHAMP Private Equity has become the latest of the established Sydney-based private equity managers to stage a take-private attempt. The target is Melbourne manufacturer Nylex Limited.
- Asian fundraising set for record-breaking year(3)
Asia’s private equity report card for the first half of this year is out: fundraising has surpassed last year’s record levels but transaction value has fallen compared to the first six months of 2006.
- Asian fundraising set for record-breaking year(2)
Asia’s private equity report card for the first half of this year is out: fundraising has surpassed last year’s record levels but transaction value has fallen compared to the first six months of 2006.
- Asian fundraising set for record-breaking year
Asia’s private equity report card for the first half of this year is out: fundraising has surpassed last year’s record levels but transaction value has fallen compared to the first six months of 2006.
- Ironbridge and Archer bid for Australia’s Symbion Health(2)
Australia-listed Symbion Health has received an unsolicited takeover proposal from a consortium of two buyout firms and a strategic rival keen to acquire Symbion’s pathology, medical centres and diagnostic imaging businesses.
- ING to raise fourth Australian fund-of-funds(2)
ING Investment Management, a pioneer in the Australian private equity fund-of-funds business, is poised to start fundraising for its fourth investment vehicle.